LSD / psilocybin / psilocin and MDMA

Compare LSD and MDMA mechanisms, examine the MDMA–DXM study, and consider the limits of those findings.

Mechanisms of action

For serotonin toxicity, an especially important pattern is increased serotonin release or reduced reuptake together with inhibition of serotonin breakdown through MAO. Many psychedelics act through 5-HT2A agonism, while MDMA increases serotonin release. Interaction concerns depend on each substance’s specific mechanism [8, 9].

The MDMA–DXM study

A controlled study involved 15 healthy men. They took MDMA by mouth, followed by DXM as a metabolic probe. DXM Cmax and AUC increased approximately tenfold, while DXO measures decreased [3].

The abstract reports CYP2D6 recovery after approximately 10 days and a recovery half-life of 46.6 hours. The full text estimates that half-life by fitting a monoexponential model to a urinary metabolic-ratio marker. At the 10-day observation, the Results and Discussion describe a remaining departure of the marker from baseline and limitations of the recovery models [3].

These findings describe pharmacokinetics and enzyme-probe measurements. The fold change can differ at other doses because of metabolic saturation and exposure-dependent inhibition. The study did not measure poisoning rates during combined recreational use or establish an individual safe waiting interval.

The authors note that the estimate appears to underestimate the time to recovery. They question the validity of a longer biphasic-model estimate because of variability in the data and insufficient data points over time [3].

Why the assessments differ

With psychological effects given relatively little weight, LSD and psilocybin rank below MDMA and MAOIs. These groups differ in the serotonin-elevating mechanisms underlying the assessment [8].

Limits of the clinical data

Targeted searching did not identify separate clinical reports with adequately described outcomes specifically for the MDMA–DXM pair. The search had limited coverage.

Comparison summary

Many psychedelics act through 5-HT2A agonism, while MDMA increases serotonin release.

Related combinations in the atlas

Comparison

Sources

Reference

Open the source and related combinations →